Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272404
Max Phase: Preclinical
Molecular Formula: C27H29N5O4
Molecular Weight: 487.56
Associated Items:
ID: ALA5272404
Max Phase: Preclinical
Molecular Formula: C27H29N5O4
Molecular Weight: 487.56
Associated Items:
Canonical SMILES: C=CC(=O)Nc1ccccc1C1CCNc2c(C(N)=O)c(-c3cc(OC)c(C4CC4)c(OC)c3)nn21
Standard InChI: InChI=1S/C27H29N5O4/c1-4-22(33)30-18-8-6-5-7-17(18)19-11-12-29-27-24(26(28)34)25(31-32(19)27)16-13-20(35-2)23(15-9-10-15)21(14-16)36-3/h4-8,13-15,19,29H,1,9-12H2,2-3H3,(H2,28,34)(H,30,33)
Standard InChI Key: NCEZXFYYHDEYFJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 487.56 | Molecular Weight (Monoisotopic): 487.2220 | AlogP: 4.07 | #Rotatable Bonds: 8 |
Polar Surface Area: 120.50 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.63 | CX Basic pKa: 2.49 | CX LogP: 3.63 | CX LogD: 3.63 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.41 | Np Likeness Score: -0.38 |
1. Guo Y, Hu N, Liu Y, Zhang W, Yu D, Shi G, Zhang B, Yin L, Wei M, Yuan X, Luo L, Wang F, Song X, Xin L, Wei Q, Li Y, Guo Y, Chen S, Zhang T, Zhang S, Zhou X, Zhang C, Su D, Liu J, Cheng Z, Zhang J, Xing H, Sun H, Li X, Zhao Y, He M, Wu Y, Guo Y, Sun X, Tian A, Zhou C, Young S, Liu X, Wang L, Wang Z.. (2023) Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases., 66 (6): [PMID:36912866] [10.1021/acs.jmedchem.2c01938] |
Source(1):